4
Changes in Ownership
Seaport Therapeutics, Inc. Filed Acc 0001193125-26-204468
Director acquired 13,406 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Torres Denice · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-04 | Conversion : show line 1 in the form | +13,406 | 13,406 | I |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +12,258 | 12,258 | D |
| 2026-05-04 | Conversion : show line 3 in the form Series B Preferred Stock | −42,105 | 0 | I |
Loading xslF345X06/ownership.xml…